437 related articles for article (PubMed ID: 30915506)
21. Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age.
Monadi M; Javadian Y; Cheraghi M; Heidari B; Amiri M
Osteoporos Int; 2015 Jul; 26(7):2013-8. PubMed ID: 25860975
[TBL] [Abstract][Full Text] [Related]
22. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.
Grant PM; Kitch D; McComsey GA; Dube MP; Haubrich R; Huang J; Riddler S; Tebas P; Zolopa AR; Collier AC; Brown TT
Clin Infect Dis; 2013 Nov; 57(10):1483-8. PubMed ID: 23943825
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of Bone Mineral Density and Its Predictors in HIV-Infected and HIV-Uninfected Older Men.
Nimitphong H; Sungkanuparph S; Saetung S; Chailurkit LO; Sritara C; Musikarat S; Ongphiphadhanakul B
Endocr Pract; 2021 Dec; 27(12):1225-1231. PubMed ID: 34343711
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
Dolan SE; Kanter JR; Grinspoon S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
[TBL] [Abstract][Full Text] [Related]
25. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
Escota GV; Mondy K; Bush T; Conley L; Brooks JT; Önen N; Patel P; Kojic EM; Henry K; Hammer J; Wood KC; Lichtenstein KA; Overton ET
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):59-67. PubMed ID: 26366785
[TBL] [Abstract][Full Text] [Related]
26. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
Hoy JF; Grund B; Roediger M; Schwartz AV; Shepherd J; Avihingsanon A; Badal-Faesen S; de Wit S; Jacoby S; La Rosa A; Pujari S; Schechter M; White D; Engen NW; Ensrud K; Aagaard PD; Carr A;
J Bone Miner Res; 2017 Sep; 32(9):1945-1955. PubMed ID: 28650589
[TBL] [Abstract][Full Text] [Related]
27. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
Bregigeon S; Galinier A; Zaegel-Faucher O; Cano CE; Obry V; Laroche H; Trijau S; Saout A; Poizot-Martin I
AIDS; 2017 Jul; 31(11):1573-1577. PubMed ID: 28426535
[TBL] [Abstract][Full Text] [Related]
28. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study.
Zeng YQ; Xiao J; Li CL; Wang Y; Zhang L; Pang XL; Wang D; Du J; Zhao HX
Chin Med J (Engl); 2020 Dec; 133(24):2940-2946. PubMed ID: 33278100
[TBL] [Abstract][Full Text] [Related]
30. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence.
Jiménez B; Sainz T; Díaz L; Mellado MJ; Navarro ML; Rojo P; González-Tomé MI; Prieto L; Martínez J; de José MI; Ramos JT; Muñoz-Fernandez MÁ;
Pediatr Infect Dis J; 2017 Jun; 36(6):578-583. PubMed ID: 28005690
[TBL] [Abstract][Full Text] [Related]
31. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
[TBL] [Abstract][Full Text] [Related]
32. The association of bone mineral density with HIV infection and antiretroviral treatment in women.
Anastos K; Lu D; Shi O; Mulligan K; Tien PC; Freeman R; Cohen MH; Justman J; Hessol NA
Antivir Ther; 2007; 12(7):1049-58. PubMed ID: 18018763
[TBL] [Abstract][Full Text] [Related]
33. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
[TBL] [Abstract][Full Text] [Related]
34. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men.
Lo Re V; Guaraldi G; Leonard MB; Localio AR; Lin J; Orlando G; Zirilli L; Rochira V; Kostman JR; Tebas P
AIDS; 2009 Oct; 23(16):2191-8. PubMed ID: 19779322
[TBL] [Abstract][Full Text] [Related]
35. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
Atencio P; Cabello A; Conesa-Buendía FM; Pérez-Tanoira R; Prieto-Pérez L; Carrillo I; Álvarez B; Arboiro-Pinel R; Díaz-Curiel M; Herrero-Beaumont G; Mediero A; Górgolas M
BMC Infect Dis; 2021 Jun; 21(1):542. PubMed ID: 34107907
[TBL] [Abstract][Full Text] [Related]
36. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
Clin Endocrinol (Oxf); 2006 Aug; 65(2):191-7. PubMed ID: 16886959
[TBL] [Abstract][Full Text] [Related]
39. Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
Santi D; Madeo B; Carli F; Zona S; Brigante G; Vescini F; Guaraldi G; Rochira V
Osteoporos Int; 2016 Mar; 27(3):1103-1114. PubMed ID: 26510848
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
